| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/06/1998 | US5705693 Cationic lipids |
| 01/06/1998 | US5705655 Compounds used to produce liposomes useful as carriers for delivering macromolecules intracellularly |
| 01/06/1998 | US5705628 DNA purification and isolation using magnetic particles |
| 01/06/1998 | US5705625 Genetic engineering; medical diagnosis |
| 01/06/1998 | US5705621 Oligomeric phosphite, phosphodiester, Phosphorothioate and phosphorodithioate compounds and intermediates for preparing same |
| 01/06/1998 | US5705617 Neurotrophic factors having altered receptor binding specificities |
| 01/06/1998 | US5705616 Proteins from yeast host strains with defects in N-glycosylation |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705611 Human GM-CSF receptor component |
| 01/06/1998 | US5705608 Polypeptides with dna sequence codes |
| 01/06/1998 | US5705606 Polypeptides for binding aggregation mediators such as fibrogen |
| 01/06/1998 | US5705484 Biologically active polypeptide fusion dimers |
| 01/06/1998 | US5705479 Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 01/06/1998 | US5705391 Modified acyl-ACP desaturase |
| 01/06/1998 | US5705389 Oligonucleotides that inhibit production of α-tumor necrosis factor |
| 01/06/1998 | US5705388 CETP Ribozymes |
| 01/06/1998 | US5705387 Heat-inducible N-degron module |
| 01/06/1998 | US5705386 Derived from microorganisms ofgenus rhodococcus with specified size |
| 01/06/1998 | US5705385 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| 01/06/1998 | US5705377 Tyrosine kinase |
| 01/06/1998 | US5705376 Gene encoding carboxypeptidase of Aspergillus niger |
| 01/06/1998 | US5705375 Growing a transgenic plant under conditions wherein alpha-amylase encoding construct is expressed |
| 01/06/1998 | US5705371 Bacterial strain of escherichia coli BKIIM B-3996 as the producer of L-threonine |
| 01/06/1998 | US5705367 Neisseria having reading frames |
| 01/06/1998 | US5705366 Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor |
| 01/06/1998 | US5705364 Mammalian cell culture process |
| 01/06/1998 | US5705363 Recombinant production of human interferon τ polypeptides and nucleic acids |
| 01/06/1998 | US5705362 Modified signal sequences |
| 01/06/1998 | US5705361 Hybrid transposon with PT operon, plasmids and bacterial strains therefor |
| 01/06/1998 | US5705360 Chemokine N-terminal deletion mutations |
| 01/06/1998 | US5705359 Expression of heterologous proteins in drosophila cells |
| 01/06/1998 | US5705358 Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from a aspergillus endoxylanase II gene |
| 01/06/1998 | US5705352 Multiple drug resistance gene of Aspergillus fumigatus |
| 01/06/1998 | US5705348 Complexing single stranded dna with transition metal compounds |
| 01/06/1998 | US5705346 Method for detecting a target nucleic acid by using an interaction of two kinds of reagents |
| 01/06/1998 | US5705340 Methods for screening class B beta-lactamase enzymes from Bacteroides fragilis |
| 01/06/1998 | US5705339 Methods for the detection of the bacterial agents causing spoilage of beer |
| 01/06/1998 | US5705337 Nucleic acid detection of ligands that bind covalently with target molecule complexes |
| 01/06/1998 | US5705335 Design of drugs involving receptor-ligand-DNA interactions |
| 01/06/1998 | US5705163 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 01/06/1998 | US5705161 Immunogenic meningococcal LPS and other membrane vesicles and vaccine therefrom |
| 01/06/1998 | US5705159 Immunoreactive peptide sequence from a 43 KD human cancer antigen |
| 01/06/1998 | US5705156 Pseudomonas exotoxins binding to cells |
| 01/06/1998 | US5705151 Anticarcinogenic agents using liposomes and genetic engineering |
| 01/06/1998 | US5705150 Antigen specific plasmacytomas and antibodies derived therefrom |
| 01/06/1998 | US5705149 Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors |
| 01/06/1998 | CA2131284C Process for production of avermectins and cultures therefor |
| 01/06/1998 | CA2108897C Genome coding phytolacca antiviral protein and a recombinant expression vector therefor |
| 01/04/1998 | CA2547678A1 Canola oil having increased oleic acid and decreased linolenic acid content |
| 01/02/1998 | DE19654574A1 Ozon-Induzierte Genexpression in Pflanzen Ozone-induced gene expression in plants |
| 01/02/1998 | DE19626234A1 Vorrichtung zur kontaminationsfreien Zu- und Abfuhr von Flüssigkeiten Apparatus for contamination-free delivery and removal of fluids |
| 01/02/1998 | DE19625049A1 Transgenes, nicht-menschliches Säugetier, das ein zusätzliches DNA-Reparaturgen enthält A transgenic non-human mammal, containing an additional DNA repair gene |
| 01/01/1998 | CA2205543A1 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |
| 12/31/1997 | WO1997049992A1 Use of a carrier material for sample preparation and detection for a genetic-engineering analysis process |
| 12/31/1997 | WO1997049991A1 Use of a carrier material for screening using cell cultures |
| 12/31/1997 | WO1997049989A2 Broad specificity affinity arrays: a qualitative approach to complex sample discrimination |
| 12/31/1997 | WO1997049834A1 Method for preparing assay supports having an ordered set of reaction zones |
| 12/31/1997 | WO1997049833A1 Method for producing hybridisation complexes whose stability is substantially independent of the base composition of two hybridised nucleic acid molecules |
| 12/31/1997 | WO1997049832A2 Method of identifying cytochrome p450 |
| 12/31/1997 | WO1997049831A1 Glyceraldehyde-3-phosphate dehydrogenase and nuclear restoration of cytoplasmic male sterility |
| 12/31/1997 | WO1997049827A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | WO1997049826A1 Living recombinant avian vaccine, using as a vector the infectious avian laryngotracheitis virus |
| 12/31/1997 | WO1997049825A1 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 12/31/1997 | WO1997049824A1 System for the production of aav vectors |
| 12/31/1997 | WO1997049823A1 Ozone-induced gene expression in plants |
| 12/31/1997 | WO1997049822A1 Gene conferring disease resistance in plants and uses thereof |
| 12/31/1997 | WO1997049821A1 Modification of cryptic splice sites in heterologous genes expressed in fungi |
| 12/31/1997 | WO1997049820A1 Methods for transferring gene into chromosome |
| 12/31/1997 | WO1997049819A1 Novel amino-terminal deblocking enzyme |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049817A1 Brain glycogen phosphorylase cancer antigen |
| 12/31/1997 | WO1997049816A1 Plant gene for p-hydroxyphenylpyruvate dioxygenase |
| 12/31/1997 | WO1997049815A1 Retinoid metabolizing protein |
| 12/31/1997 | WO1997049814A1 Gene expression in plants |
| 12/31/1997 | WO1997049813A2 Glucuronide repressors and uses thereof |
| 12/31/1997 | WO1997049812A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 12/31/1997 | WO1997049811A1 Genetic control of flowering |
| 12/31/1997 | WO1997049810A1 Genetic control of polar auxin transport in plants and manipulation of plant growth, architecture and morphogenesis |
| 12/31/1997 | WO1997049809A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 12/31/1997 | WO1997049808A1 The caip-like gene family |
| 12/31/1997 | WO1997049807A2 A NOVEL HYPERTENSION RELATED CALCIUM REGULATED GENE (HCaRG) |
| 12/31/1997 | WO1997049806A1 Sexing gene |
| 12/31/1997 | WO1997049805A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 12/31/1997 | WO1997049804A1 Chromosomal rearrangement by insertion of two recombination substrates |
| 12/31/1997 | WO1997049802A1 Transgenic, non-human mammal containing an additional dna repair gene |
| 12/31/1997 | WO1997049800A1 Anti-cocaine catalytic antibody |
| 12/31/1997 | WO1997049797A1 A cell-free system for initiation of dna replication |
| 12/31/1997 | WO1997049769A1 4,7-dichlororhodamine dyes |
| 12/31/1997 | WO1997049727A1 Aatt promoter element and transcription factor |
| 12/31/1997 | WO1997049725A1 Modified factor viii |
| 12/31/1997 | WO1997049718A2 Conjugates of an oligonucleotide/electronic conductor polymer with a molecule of interest, and their uses |
| 12/31/1997 | WO1997049714A1 Process for combining parallel oligonucleotide synthesis and preparation of oligomer chips |
| 12/31/1997 | WO1997049428A1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 12/31/1997 | WO1997049417A1 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof |
| 12/31/1997 | WO1997049416A1 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/31/1997 | WO1997049289A1 Vibrio cholerae having increased sensitivity to antibiotics |
| 12/31/1997 | WO1997049277A1 DISEASE RESISTANCE IN $i(VITIS) |
| 12/31/1997 | WO1997045528A3 Mammalian tolloid-like gene and protein |
| 12/31/1997 | WO1997044469A3 Multiple epitope fusion protein |
| 12/31/1997 | WO1997044454A3 Human phospholipase inhibitor |